「president」の検索結果
24件：16～20件目を表示
もしかして
-
ent of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that the orphan drug designatio...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708.pdf -
ent of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces that the orphan drug designatio...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708_0.pdf -
Ltd. Launch of Distribution of RET-700 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter “Senju”) hereby announces the launch of distribution of R...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726.pdf -
rmulation of Aibeta® combination eye drops Senju Pharmaceutical Co., Ltd. (Head Office: Osaka City, President: Shuhei Yoshida) announced today that it has obtained approval for a partial change in the...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904_0.pdf -
vel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida; hereinafter: Senju) is developing a TRPV1 antagonist (development cod...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf